쮸떴눈첵

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

BioNTech

In the last 7 days

GlobeNewswire (Press Release)07:46 31-Oct-24

Drug Discovery & Development01:50 31-Oct-24

PR Newswire (Press Release)07:05 29-Oct-24

In the last month

NBC Connecticut17:27 25-Oct-24

Zacks11:36 25-Oct-24

The New Times06:29 24-Oct-24

Annenberg Political Fact Check18:14 22-Oct-24

Scrip Pharma Intelligence13:49 22-Oct-24

Scrip Pharma Intelligence13:49 22-Oct-24

Scrip Pharma Intelligence12:32 21-Oct-24

Seeking Alpha11:25 21-Oct-24

Clinical Trials Arena09:25 21-Oct-24

GlobeNewswire (Press Release)06:47 21-Oct-24

Simply Wall St16:11 18-Oct-24

FierceBiotech13:05 18-Oct-24

Barchart12:54 18-Oct-24

ENDPOINTS11:28 18-Oct-24

TipRanks09:37 18-Oct-24

Scrip Pharma Intelligence01:32 16-Oct-24

Scrip Pharma Intelligence01:32 16-Oct-24

Yahoo! US12:56 12-Oct-24

TechCrunch12:09 12-Oct-24

Thomson Reuters - Practical Law08:34 8-Oct-24

GOV.UK (Press Release)08:12 8-Oct-24

DD News06:15 8-Oct-24

Singularity Hub10:01 7-Oct-24

Louisville Public Media12:05 6-Oct-24

HumanProgress14:22 4-Oct-24

ENDPOINTS15:53 2-Oct-24

view more headlines

31 Oct 07:46

About our BioNTech news

Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.